<?xml version='1.0' encoding='UTF-8'?>
<search_results><query id="7215">squamous cell carcinoma</query><engine status="OK" timestamp="2014-04-21 18:46:42" name="The Street" id="FW14-e108"/><snippets><snippet id="FW14-e108-7215-01"><link cache="FW14-topics-docs/e108/7215_01.html" timestamp="2014-04-21 18:46:43">http://www.thestreet.com/story/10277059/1/imclone-gets-milestone-payment.html</link><title>ImClone Gets Milestone Payment</title><description>ImClone Gets Milestone Payment

By Althea Chang 11:56 AM EDT 04/03/06

The $250 million payment from Bristol-Myers will be the last one under their agreement.

http://www.thestreet.com/story/10277059/1/imclone-gets-milestone-payment.html</description></snippet><snippet id="FW14-e108-7215-02"><link cache="FW14-topics-docs/e108/7215_02.html" timestamp="2014-04-21 18:50:23">http://www.thestreet.com/story/10227054/1/icahn-and-erbitux-energize-imclone.html</link><title>Icahn and Erbitux Energize ImClone</title><description>Icahn and Erbitux Energize ImClone

By TSC Staff 11:45 AM EDT 06/08/05

The company says an analysis finds Erbitux used with radiation helps treat head and neck cancer.

http://www.thestreet.com/story/10227054/1/icahn-and-erbitux-energize-imclone.html</description></snippet><snippet id="FW14-e108-7215-03"><link cache="FW14-topics-docs/e108/7215_03.html" timestamp="2014-04-21 18:54:14">http://www.thestreet.com/story/10312641/1/cytokinetics-drug-fails-trial.html</link><title>Cytokinetics Drug Fails Trial</title><description>Cytokinetics Drug Fails Trial

By Althea Chang 01:36 PM EDT 10/03/06

The study involved the experimental head-and-neck cancer drug ispinesib.

http://www.thestreet.com/story/10312641/1/cytokinetics-drug-fails-trial.html</description></snippet><snippet id="FW14-e108-7215-04"><link cache="FW14-topics-docs/e108/7215_04.html" timestamp="2014-04-21 18:56:37">http://www.thestreet.com/story/10240268/1/imclone-files-for-new-erbitux-use.html</link><title>ImClone Files for New Erbitux Use</title><description>ImClone Files for New Erbitux Use

By TSC Staff 09:00 AM EDT 08/30/05

The company asks the FDA to approve Erbitux as a treatment for head and neck cancer.

http://www.thestreet.com/story/10240268/1/imclone-files-for-new-erbitux-use.html</description></snippet><snippet id="FW14-e108-7215-05"><link cache="FW14-topics-docs/e108/7215_05.html" timestamp="2014-04-21 18:58:01">http://www.thestreet.com/story/10228715/1/imclone-to-seek-added-erbitux-use-in-third-quarter.html</link><title>ImClone to Seek Added Erbitux Use in Third Quarter</title><description>ImClone to Seek Added Erbitux Use in Third Quarter

By TSC Staff 09:02 AM EDT 06/20/05

The company will try to gain approval to use the drug for head and neck cancer.

http://www.thestreet.com/story/10228715/1/imclone-to-seek-added-erbitux-use-in-third-quarter.html</description></snippet><snippet id="FW14-e108-7215-06"><link cache="FW14-topics-docs/e108/7215_06.html" timestamp="2014-04-21 18:59:43">http://www.thestreet.com/story/10431221/1/bristol-myers-offers-60share-for-imclone.html</link><title>Bristol-Myers Offers $60/Share for ImClone</title><description>Bristol-Myers Offers $60/Share for ImClone

By TSC Staff 08:59 AM EDT 07/31/08

ImClone shares are soaring on news of the $4.5 billion cash bid.

http://www.thestreet.com/story/10431221/1/bristol-myers-offers-60share-for-imclone.html</description></snippet><snippet id="FW14-e108-7215-07"><link cache="FW14-topics-docs/e108/7215_07.html" timestamp="2014-04-21 19:01:26">http://www.thestreet.com/story/10172481/1/imclone-bristol-myers-to-file-for-additional-erbitux-use.html</link><title>ImClone, Bristol-Myers to File for Additional Erbitux Use</title><description>ImClone, Bristol-Myers to File for Additional Erbitux Use

By Eric Gillin 05:01 PM EDT 07/20/04

The drug may show promise in fighting head and neck cancer.

http://www.thestreet.com/story/10172481/1/imclone-bristol-myers-to-file-for-additional-erbitux-use.html</description></snippet><snippet id="FW14-e108-7215-08"><link cache="FW14-topics-docs/e108/7215_08.html" timestamp="2014-04-21 19:02:59">http://www.thestreet.com/story/10819364/1/allos-folotyn-survival-trend-in-lung-cancer.html</link><title>Allos: Folotyn Survival Trend in Lung Cancer</title><description>Allos: Folotyn Survival Trend in Lung Cancer

By Adam Feuerstein 08:34 AM EDT 07/28/10

Allos' cancer drug fares well in small lung cancer study but quarterly sales fall below consensus.

http://www.thestreet.com/story/10819364/1/allos-folotyn-survival-trend-in-lung-cancer.html</description></snippet><snippet id="FW14-e108-7215-09"><link cache="FW14-topics-docs/e108/7215_09.html" timestamp="2014-04-21 19:06:13">http://www.thestreet.com/story/10223605/1/imclone-hopes-for-broader-erbitux-role.html</link><title>ImClone Hopes for Broader Erbitux Role</title><description>ImClone Hopes for Broader Erbitux Role

By TSC Staff 09:03 AM EDT 05/16/05

At this year's ASCO meeting, the company presented results from a variety of studies.

http://www.thestreet.com/story/10223605/1/imclone-hopes-for-broader-erbitux-role.html</description></snippet><snippet id="FW14-e108-7215-10"><link cache="FW14-topics-docs/e108/7215_10.html" timestamp="2014-04-21 19:08:38">http://www.thestreet.com/story/12030933/1/oncolytics-pumps-stock-with-worsening-lung-cancer-drug-data.html</link><title>Oncolytics Pumps Stock With Worsening Lung Cancer Drug Data</title><description>Oncolytics Pumps Stock With Worsening Lung Cancer Drug Data

By Adam Feuerstein 12:31 PM EDT 09/09/13

Oncolytics claims positive Reolysin results, fails to mention falling response rates.

http://www.thestreet.com/story/12030933/1/oncolytics-pumps-stock-with-worsening-lung-cancer-drug-data.html</description><thumb cache="FW14-topics-docs/e108/7215_10_thumb.jpg">http://i.thestreet.com/files/tsc/v2008/photos/all-pics/101612_biotech11_139x90.jpg</thumb></snippet></snippets></search_results>